AstraZeneca (AZN): news on Tuesday 20 October 2026

The 24 stories

Each headline's own score, strongest first. Links go to the publisher.

• +9.2 AstraZeneca to present overall survival data from four pivotal Phase III trials in Presidential Symposia at ESMO 2026 featuring Sone-Ve, IMFINZI® (durvalumab), TAGRISSO® (osimertinib) and savolitinib Business Wire
  Overall survival data in Presidential Symposia, a prestigious slot.
• +7.5 CHMP Backs Extended Use of AstraZeneca H5N1 Pandemic Flu Vaccine Contagion Live
  CHMP backs extended use of its pandemic flu vaccine.
• +7.5 AstraZeneca to present data from four Phase III trials at ESMO 2026 StreetInsider
  Four Phase III trials to be presented at ESMO.
• +7.0 AstraZeneca to Present Survival Data From Four Trials at ESMO 2026 Mirage News
  Survival data from four trials at ESMO.
• +6.7 AstraZeneca to unveil major oncology advances at the 2026 ESMO Congress marketscreener.com
  Major oncology advances to be unveiled.
• +6.7 AstraZeneca signs USD 40 million AI deal. Citi targets AstraZeneca stock at GBp 18,600 - ad-hoc-news.de ad-hoc-news.de
  AI deal and high Citi price target.
• +5.8 AstraZeneca, Oracle to launch their first global AI program in Abu Dhabi: CEO CNBC
  First global AI programme launching in Abu Dhabi.
• +5.8 AstraZeneca Partners With Oracle to Refine Clinical Research With AI WSJ
  AI partnership with Oracle on clinical research.
• +5.8 AstraZeneca announces new data across portfolio at ESMO 2026 TipRanks
  New data across portfolio at ESMO.
• +5.5 Oracle and AstraZeneca Partner to Advance AI-enabled Healthcare Innovation PR Newswire
  Official release of AI healthcare partnership.
• +5.3 Astrazeneca And Oracle Launch Global AI Collaboration To Advance Clinical Trial Optimisation And Support Better Patient Outcomes TradingView
  Global AI collaboration to optimise clinical trials.
• +5.0 AI may help doctors identify trial candidates sooner. Oracle and AstraZeneca will explore how. Stock Titan
  AI may speed identification of trial candidates.
• +5.0 Oracle, AstraZeneca team up on AI innovation Breakingthenews.net
  Oracle AI collaboration announced.
• +5.0 AstraZeneca Partners with Oracle for AI Collaboration on Trials, Patient Care marketscreener.com
  AI collaboration on trials and patient care.
• −5.0 CHMP October decisions: AstraZeneca pulls prostate cancer filing; Orphelia gets a second chance; Ascendis nears EU launch European Biotechnology Magazine
  Pulls prostate cancer filing in EU.
• +5.0 Oracle and AstraZeneca team up to use AI and re... Pluang
  Oracle AI collaboration announced.
• +5.0 AstraZeneca stock: RBC keeps target at GBp 14,500 for AstraZeneca stock - ad-hoc-news.de ad-hoc-news.de
  RBC maintains high price target.
• +5.0 Fadnavis Inaugurates AstraZeneca's New Mumbai Office Rediff MoneyWiz
  New Mumbai office inaugurated, signalling expansion.
• −4.2 AstraZeneca shares technical analysis: Downward price move meets GBX12,344 support Traders Union
  Share price falling toward support level.
• −3.3 AstraZeneca, Pharmacor Clash Over Diabetes Drug Patent Law360
  Diabetes drug patent clash with Pharmacor.
• −3.3 AstraZeneca argues Pharmacor’s IP case lacks common sense Lawyerly
  Patent dispute with Pharmacor, company defending.
• +1.7 “Don’t call it continuous!” AstraZeneca expert talks integrated bioprocessing at BPI BioProcess International
  Company expert speaking at industry conference.
• +1.7 AstraZeneca stock: ESMO event on October 26 ahead of Xetra open - ad-hoc-news.de ad-hoc-news.de
  Upcoming ESMO event preview, mildly positive.
• +0.5 Arber Shehu Takes on New Role as Director of Global Partnerships in Lung Cancer at AstraZeneca Oncodaily
  Minor staff appointment news.